Table IV. Outcomes of the assessed PROs using EQ-VAS.

EQ-VAS *	T0 (baseline)	T1 (FET)	T2 (pregnancy test)	Treatment effect	Time effect	Interaction
Mean (SD)
Home-based monitoring	n = 116; 83.35 (10.83)	n = 97; 81.79 (10.27)	n = 91; 80.43 (12.54)	P = 0.99	P = 0.34	P = 0.36
Hospital-based monitoring	n = 116; 81.48 (12.89)	n = 90; 82.88 (11.88)	n = 84; 81.18 (11.51)
Median (−25th, −75th)
Home-based monitoring	n = 116; 82.50 (80.00–90.00)	n = 97; 80.00 (75.00–90.00)	n = 91; 80.00 (73.00–90.00)
Hospital-based monitoring	n = 116; 80.50 (75.00–90.00)	n = 90; 84.50 (75.00–92.00)	n = 84; 81.00 (76.00–89.8)

Data for the two randomisation groups of the Antarctica-2 RCT before randomisation (T = 0), after completion of ovulation monitoring but before FET (T = 1) and before pregnancy test (T = 2).

VAS, visual analogue scale.

^*Scale ranging from 0 (worst possible health status) to 100 (best possible health status).